Summary of Molecular Glues Approved or in Clinical Trial | Biopharma PEG
Chasing molecular glue degraders: screening approaches - Chemical Society Reviews (RSC Publishing) DOI:10.1039/D2CS00197G
Molecules | Free Full-Text | PROTACs: Emerging Targeted Protein Degradation Approaches for Advanced Druggable Strategies
Molecular glues are beginning to stick
Targeted protein degradation: A new direction for treatment of diseases - Research Outreach
Targeted Protein Degradation Approaches and Applications
MG-277, a PROTAC Molecular Glue, Exhibits Anti-cancer Activity by Inhibiting GSPT1 - Network of Cancer Research
Schematic representation of hydrophobic tagging (HyT), molecular glue... | Download Scientific Diagram
Tragedy to Transformation – Molecular Glue Sparks the Field of Targeted Protein Degradation - LifeSensors
PROTACs, molecular glues and bifunctionals from bench to bedside: Unlocking the clinical potential of catalytic drugs - ScienceDirect
Molecular Glues: A New Dawn After PROTAC | Biopharma PEG
Molecular recognition of ternary complexes: a new dimension in the structure-guided design of chemical degraders. - Abstract - Europe PMC
PROTACs, molecular glues and bifunctionals from bench to bedside: Unlocking the clinical potential of catalytic drugs - ScienceDirect
PROTACs and Molecular Glues
PROTACs, molecular glues and bifunctionals from bench to bedside: Unlocking the clinical potential of catalytic drugs - ScienceDirect
Molecular Glues: A New Dawn After PROTAC | Biopharma PEG
Clinical Translation of Targeted Protein Degraders - Kong - 2023 - Clinical Pharmacology & Therapeutics - Wiley Online Library
Targeted protein degradation: mechanisms, strategies and application | Signal Transduction and Targeted Therapy
Molecular glues modulate protein functions by inducing protein aggregation: A promising therapeutic strategy of small molecules for disease treatment | Semantic Scholar
Targeted Protein Destruction: Advances in PROTACs Other Degraders
Molecular glues: enhanced protein-protein interactions and cell proteome editing | Medicinal Chemistry Research
Cancers | Free Full-Text | Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent Kinase
PROTACs, molecular glues and bifunctionals from bench to bedside: Unlocking the clinical potential of catalytic drugs - ScienceDirect
12 Types of Targeted Protein Degradation Technologies | Biopharma PEG
